Novo Nordisk's blockbuster diabetes drug Ozempic and weight-loss treatment Wegovy are among the 15 drugs targeted for Medicare price negotiations for 2027. Novo Nordisk's blockbuster diabetes drug ...

About 65 million are covered by Medicare. The drugs selected for price negotiations are among those with "highest total spending" for Medicare Part D, according to the White House. When the new ...

In 2023, Medicare selected 10 drugs for its first round of price negotiations. Agreements were reached with drug manufacturers to establish new, reduced prices for all 10 drugs. These prices ...

President Trump has signed his executive order seeking lower prescription drug prices. It gives the pharmaceutical industry ...

Will Medicare's price negotiations save money and lives or hurt patients by discouraging the development of the next generation of blockbuster drugs? From our morning news briefing to a weekly ...

This change would mean that small molecule drugs would be on the market longer before they are eligible to be selected for Medicare drug price negotiation, which could lead to higher Medicare ...

Such a change has the potential to increase costs for the government, because it would most likely delay the existing timetable for some drugs to become eligible for Medicare price cuts.

Kennedy Jr. to work with Congress to modify a piece of the Medicare drug price negotiation rules, which differentiate between small-molecule drugs and biologic medicines. Get top local stories in ...